Aevi Genomic Medicine Announces Enrollment of First Patient in Phase 1/2 Clinical Trial of AEVI-001 in 22q Deletion Syndrome Genetics Investing
Momenta Pharmaceuticals Announces District Court Decision to Invalidate Teva Patents in COPAXONE® Litigation Pharmaceutical Investing
Cellectar Biosciences Demonstrates Capabilities of the PDC Platform in Two Peer Reviewed Studies Biotech Investing
Incyte and Calithera Biosciences Announce Global Collaboration to Develop and Commercialize CB-1158, a First-in-class, Small Molecule Arginase Inhibitor Biotech Investing
BioCryst Announces the Acceptance of Peramivir MAA Filing by the European Medicines Agency Biotech Investing
uniQure Announces FDA Breakthrough Therapy Designation for AMT-060 in Hemophilia B Genetics Investing
PharmaCyte Biotech Retains Facet Life Sciences to Guide Pancreatic Cancer Therapy Development Lifecycle with FDA Biotech Investing
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026Â
